Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Trends in Cardiovascular Disease Morbidity and Mortality in American Indians Over 25 Years: The Strong Heart Study.

Muller CJ, Noonan CJ, MacLehose RF, Stoner JA, Lee ET, Best LG, Calhoun D, Jolly SE, Devereux RB, Howard BV.

J Am Heart Assoc. 2019 Nov 5;8(21):e012289. doi: 10.1161/JAHA.119.012289. Epub 2019 Oct 25.

2.

Incident Atrial Fibrillation Among American Indians in California.

Sanchez JM, Jolly SE, Dewland TA, Tseng ZH, Nah G, Vittinghoff E, Marcus GM.

Circulation. 2019 Nov 5;140(19):1605-1606. doi: 10.1161/CIRCULATIONAHA.119.042882. Epub 2019 Oct 21. No abstract available.

PMID:
31630530
3.

Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.

Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV Jr, Nakhoul GN.

Nephron. 2019;141(1):31-40. doi: 10.1159/000494047. Epub 2018 Oct 26.

PMID:
30368506
4.

Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.

Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV Jr, Navaneethan SD.

Am J Nephrol. 2018;48(1):36-45. doi: 10.1159/000491023. Epub 2018 Jul 26.

5.

Provider Variation in Antibiotic Prescribing and Outcomes of Respiratory Tract Infections.

Manne M, Deshpande A, Hu B, Patel A, Taksler GB, Misra-Hebert AD, Jolly SE, Brateanu A, Bales RW, Rothberg MB.

South Med J. 2018 Apr;111(4):235-242. doi: 10.14423/SMJ.0000000000000795.

PMID:
29719037
6.

High-density lipoprotein cholesterol and causes of death in chronic kidney disease.

Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV Jr.

J Clin Lipidol. 2018 Jul - Aug;12(4):1061-1071.e7. doi: 10.1016/j.jacl.2018.03.085. Epub 2018 Mar 30.

7.

Impact of Uric Acid Levels on Kidney Disease Progression.

Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV Jr, Rothberg MB.

Am J Nephrol. 2017;46(4):315-322. doi: 10.1159/000481460. Epub 2017 Oct 13.

PMID:
29032376
8.

Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.

Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1418-1427. doi: 10.2215/CJN.02100217. Epub 2017 Aug 4.

9.

Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV Jr.

Kidney Int. 2017 Nov;92(5):1272-1281. doi: 10.1016/j.kint.2017.04.030. Epub 2017 Jul 24.

10.

Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr.

Am J Kidney Dis. 2017 Aug;70(2):191-198. doi: 10.1053/j.ajkd.2016.11.018. Epub 2017 Feb 10.

11.

Associations of dysnatremias with mortality in chronic kidney disease.

Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1204-1210. doi: 10.1093/ndt/gfw209.

12.

Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.

Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV Jr.

Am J Nephrol. 2016;43(1):39-46. doi: 10.1159/000444422. Epub 2016 Feb 19.

13.

Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.

Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV Jr, Navaneethan SD.

Am J Nephrol. 2015;41(6):456-63. doi: 10.1159/000437151. Epub 2015 Jul 25.

14.

Cause-Specific Deaths in Non-Dialysis-Dependent CKD.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV Jr.

J Am Soc Nephrol. 2015 Oct;26(10):2512-20. doi: 10.1681/ASN.2014101034. Epub 2015 Jun 4.

15.

Development of a chronic kidney disease patient navigator program.

Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV.

BMC Nephrol. 2015 May 3;16:69. doi: 10.1186/s12882-015-0060-2.

16.

Cardiometabolic correlates of low type 2 diabetes incidence in western Alaska Native people - The WATCH study.

Koller KR, Metzger JS, Jolly SE, Umans JG, Hopkins SE, Kaufmann C, Wilson AS, Ebbesson SO, Raymer TW, Austin MA, Howard BV, Boyer BB.

Diabetes Res Clin Pract. 2015 Jun;108(3):423-31. doi: 10.1016/j.diabres.2015.03.001. Epub 2015 Mar 11.

17.

Prevalence of Hypertension and Associated Risk Factors in Western Alaska Native People: The Western Alaska Tribal Collaborative for Health (WATCH) Study.

Jolly SE, Koller KR, Metzger JS, Day GM, Silverman A, Hopkins SE, Austin MA, Boden-Albala B, Ebbesson SO, Boyer BB, Howard BV, Umans JG.

J Clin Hypertens (Greenwich). 2015 Oct;17(10):812-8. doi: 10.1111/jch.12483. Epub 2015 Feb 3.

18.

All-cause, cardiovascular, and cancer mortality in western Alaska Native people: western Alaska Tribal Collaborative for Health (WATCH).

Howard BV, Metzger JS, Koller KR, Jolly SE, Asay ED, Wang H, Wolfe AW, Hopkins SE, Kaufmann C, Raymer TW, Trimble B, Provost EM, Ebbesson SO, Austin MA, Howard WJ, Umans JG, Boyer BB.

Am J Public Health. 2014 Jul;104(7):1334-40. doi: 10.2105/AJPH.2013.301614. Epub 2014 Apr 22.

19.

Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality.

Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV.

Am J Nephrol. 2014;39(4):288-96. doi: 10.1159/000360306. Epub 2014 Apr 1.

20.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV Jr, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Am J Kidney Dis. 2014 May;63(5):806-15. doi: 10.1053/j.ajkd.2013.12.010. Epub 2014 Feb 6.

21.

Albuminuria: when urine predicts kidney and cardiovascular disease.

Stephen R, Jolly SE, Nally JV Jr, Navaneethan SD.

Cleve Clin J Med. 2014 Jan;81(1):41-50. doi: 10.3949/ccjm.81a.13040. Review.

PMID:
24391106
22.

Cardiovascular Disease Among Alaska Native Peoples.

Jolly SE, Howard BV, Umans JG.

Curr Cardiovasc Risk Rep. 2013 Dec 1;7(6). doi: 10.1007/s12170-013-0362-5.

23.

Utilizing harmonization and common surveillance methods to consolidate 4 cohorts: the Western Alaska Tribal Collaborative for Health (WATCH) study.

Koller KR, Wolfe AW, Metzger JS, Austin MA, Hopkins SE, Kaufmann C, Jolly SE, Ebbesson SO, Umans JG, Howard BV, Boyer BB.

Int J Circumpolar Health. 2013 May 2;72. doi: 10.3402/ijch.v72i0.20572. Print 2013.

24.

Metabolic syndrome, ESRD, and death in CKD.

Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV Jr.

Clin J Am Soc Nephrol. 2013 Jun;8(6):945-52. doi: 10.2215/CJN.09870912. Epub 2013 Feb 14.

25.

Electronic health records: a new tool to combat chronic kidney disease?

Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ Jr, Nally JV Jr.

Clin Nephrol. 2013 Mar;79(3):175-83. doi: 10.5414/CN107757.

26.

Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study.

Shara NM, Wang H, Mete M, Al-Balha YR, Azalddin N, Lee ET, Franceschini N, Jolly SE, Howard BV, Umans JG.

Am J Kidney Dis. 2012 Nov;60(5):795-803. doi: 10.1053/j.ajkd.2012.06.015. Epub 2012 Jul 25.

27.

Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr.

Nephrol Dial Transplant. 2012 Aug;27(8):3228-34. doi: 10.1093/ndt/gfs058. Epub 2012 May 2.

28.

Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Jolly SE, Mete M, Wang H, Zhu J, Ebbesson SO, Voruganti VS, Comuzzie AG, Howard BV, Umans JG.

J Clin Hypertens (Greenwich). 2012 Feb;14(2):71-7. doi: 10.1111/j.1751-7176.2011.00574.x. Epub 2012 Jan 4.

29.

Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).

Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, Bakris G, McCullough PA, Shlipak M; KEEP Investigators.

Arch Intern Med. 2012 Jan 9;172(1):41-7. doi: 10.1001/archinternmed.2011.619.

30.

Regional differences in dialysis care and mortality among American Indians and Alaska Natives.

Hall YN, Jolly SE, Xu P, Abrass CK, Buchwald D, Himmelfarb J.

J Am Soc Nephrol. 2011 Dec;22(12):2287-95. doi: 10.1681/ASN.2011010054. Epub 2011 Oct 6.

31.

Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ Jr, Nally JV Jr.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2395-402. doi: 10.2215/CJN.03730411. Epub 2011 Sep 1.

32.

Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ Jr, Simon JF, Srinivas TR, Nally JV Jr.

Am J Kidney Dis. 2011 Oct;58(4):536-43. doi: 10.1053/j.ajkd.2011.04.028. Epub 2011 Aug 4.

33.

Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Norris KC, Shlipak MG.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1858-65. doi: 10.2215/CJN.00500111. Epub 2011 Jul 22.

34.

Sex-specific associations of nutrition with hypertension and systolic blood pressure in Alaska Natives findings from the GOCADAN study.

Jolly SE, Eilat-Adar S, Wang H, Mete M, Fabsitz RR, Devereux RB, Ebbesson SO, Umans JG, Howard BV.

Int J Circumpolar Health. 2011 Jun;70(3):254-65. Epub 2011 May 26.

35.

Implications of the CKD-EPI GFR estimation equation in clinical practice.

Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ Jr, Nally JV Jr.

Clin J Am Soc Nephrol. 2011 Mar;6(3):497-504. doi: 10.2215/CJN.04240510. Epub 2010 Nov 29.

36.

Development and validation of an electronic health record-based chronic kidney disease registry.

Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ Jr, Jain A, Nally JV Jr.

Clin J Am Soc Nephrol. 2011 Jan;6(1):40-9. doi: 10.2215/CJN.04230510. Epub 2010 Nov 4.

37.

Albuminuria among Alaska Natives--findings from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Jolly SE, Noonan CJ, Roubideaux YD, Goldberg JH, Ebbesson SO, Umans JG, Howard BV.

Nephron Clin Pract. 2010;115(2):c107-13. doi: 10.1159/000312873. Epub 2010 Apr 21.

38.

Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Narva AS, Norris KC, Shlipak MG.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S15-22. doi: 10.1053/j.ajkd.2009.09.034.

39.

Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program.

Jolly SE, Li S, Chen SC, Narva AS, Jurkovitz CT, Norris KC, Shlipak MG.

Am J Nephrol. 2009;29(5):440-6. doi: 10.1159/000174857. Epub 2008 Nov 14.

40.

Clinical categorization for elective surgery in Victoria.

Russell C, Roberts M, Williamson TG, McKercher J, Jolly SE, McNeil J.

ANZ J Surg. 2003 Oct;73(10):839-42.

PMID:
14525579
41.

The anticoagulant pindone causes liver damage in the brushtail possum (Trichosurus vulpecula).

Jolly SE, Eason CT, Frampton C, Gumbrell RC.

Aust Vet J. 1994 Jul;71(7):220. No abstract available.

PMID:
7945103
42.
43.

Supplemental Content

Loading ...
Support Center